These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. Targeted Inhibition of Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Sensitizes Pancreatic Cancer Cells to Doxorubicin without Exacerbating Cardiac Toxicity. Durrant DE; Das A; Dyer S; Tavallai S; Dent P; Kukreja RC Mol Pharmacol; 2015 Sep; 88(3):512-23. PubMed ID: 26101222 [TBL] [Abstract][Full Text] [Related]
48. Cardioprotective effects of curcumin and nebivolol against doxorubicin-induced cardiac toxicity in rats. Imbaby S; Ewais M; Essawy S; Farag N Hum Exp Toxicol; 2014 Aug; 33(8):800-13. PubMed ID: 24648241 [TBL] [Abstract][Full Text] [Related]
49. Concomitant low-dose doxorubicin treatment and exercise. Sturgeon K; Schadler K; Muthukumaran G; Ding D; Bajulaiye A; Thomas NJ; Ferrari V; Ryeom S; Libonati JR Am J Physiol Regul Integr Comp Physiol; 2014 Sep; 307(6):R685-92. PubMed ID: 25009215 [TBL] [Abstract][Full Text] [Related]
50. GATA4-targeted compound exhibits cardioprotective actions against doxorubicin-induced toxicity in vitro and in vivo: establishment of a chronic cardiotoxicity model using human iPSC-derived cardiomyocytes. Karhu ST; Kinnunen SM; Tölli M; Välimäki MJ; Szabó Z; Talman V; Ruskoaho H Arch Toxicol; 2020 Jun; 94(6):2113-2130. PubMed ID: 32185414 [TBL] [Abstract][Full Text] [Related]
51. Doxorubicin induced apoptosis was potentiated by neferine in human lung adenocarcima, A549 cells. Poornima P; Kumar VB; Weng CF; Padma VV Food Chem Toxicol; 2014 Jun; 68():87-98. PubMed ID: 24632453 [TBL] [Abstract][Full Text] [Related]
52. Saffron extracts alleviate cardiomyocytes injury induced by doxorubicin and ischemia-reperfusion in vitro. Chahine N; Nader M; Duca L; Martiny L; Chahine R Drug Chem Toxicol; 2016; 39(1):87-96. PubMed ID: 25885550 [TBL] [Abstract][Full Text] [Related]
55. Liposomal doxorubicin attenuates cardiotoxicity via induction of interferon-related DNA damage resistance. Gyöngyösi M; Lukovic D; Zlabinger K; Spannbauer A; Gugerell A; Pavo N; Traxler D; Pils D; Maurer G; Jakab A; Riesenhuber M; Pircher A; Winkler J; Bergler-Klein J Cardiovasc Res; 2020 Apr; 116(5):970-982. PubMed ID: 31346605 [TBL] [Abstract][Full Text] [Related]
56. Prevention of doxorubicin (DOX)-induced genotoxicity and cardiotoxicity: Effect of plant derived small molecule indole-3-carbinol (I3C) on oxidative stress and inflammation. Hajra S; Patra AR; Basu A; Bhattacharya S Biomed Pharmacother; 2018 May; 101():228-243. PubMed ID: 29494960 [TBL] [Abstract][Full Text] [Related]
57. JAK2/STAT3 Pathway Mediates Protection of Metallothionein Against Doxorubicin-Induced Cytotoxicity in Mouse Cardiomyocytes. Rong J; Li L; Jing L; Fang H; Peng S Int J Toxicol; 2016 May; 35(3):317-26. PubMed ID: 26526549 [TBL] [Abstract][Full Text] [Related]
58. The anti-cancer drug doxorubicin induces substantial epigenetic changes in cultured cardiomyocytes. Hanf A; Oelze M; Manea A; Li H; Münzel T; Daiber A Chem Biol Interact; 2019 Nov; 313():108834. PubMed ID: 31545955 [TBL] [Abstract][Full Text] [Related]
59. Circular RNA Arhgap12 modulates doxorubicin-induced cardiotoxicity by sponging miR-135a-5p. Wang X; Cheng Z; Xu J; Feng M; Zhang H; Zhang L; Qian L Life Sci; 2021 Jan; 265():118788. PubMed ID: 33245966 [TBL] [Abstract][Full Text] [Related]
60. Possible Mechanisms of the Prevention of Doxorubicin Toxicity by Cichoric Acid-Antioxidant Nutrient. Jabłońska-Trypuć A; Krętowski R; Kalinowska M; Świderski G; Cechowska-Pasko M; Lewandowski W Nutrients; 2018 Jan; 10(1):. PubMed ID: 29303987 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]